fosinopril has been researched along with Arteriosclerosis in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (81.82) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guan, S; Wang, B | 1 |
| Aberg, G; Andersson, RG; Jacobsson, LS; Karlberg, BE; Olsson, AG; Persson, K | 1 |
| Aberg, G; Beyer, S; Kowala, MC; Recce, R | 1 |
| Ambrosioni, E; Bacchelli, S; Borghi, C | 1 |
| Aberg, G; Grove, RI; Kowala, MC | 1 |
| Andersson, RG; Jacobsson, L; Persson, K | 1 |
| Zanchetti, A | 1 |
| Gerolimou, B; Hatzigakis, SM; Karmaniolas, KD; Kozanidou, G; Migdalis, IN | 1 |
| Attias, J; Breslow, JL; Brodsky, S; Coleman, R; Hayek, T; Keidar, S; Smith, J | 1 |
| Bitzur, R; Grossman, E; Harats, D; Levkovitz, H; Shaish, A; Sharabi, Y; Sherer, Y | 1 |
2 review(s) available for fosinopril and Arteriosclerosis
| Article | Year |
|---|---|
The use of zofenopril and fosinopril in acute myocardial infarction and carotid artery disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Captopril; Carotid Artery Diseases; Clinical Trials as Topic; Fosinopril; Humans; Myocardial Infarction | 1994 |
The hypertensive patient with multiple risk factors: is treatment really so difficult?
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Animals; Anticholesteremic Agents; Antihypertensive Agents; Arteriosclerosis; Clinical Trials as Topic; Coronary Disease; Female; Fosinopril; Humans; Hydrochlorothiazide; Hypercholesterolemia; Hypertension; Male; Middle Aged; Pravastatin; Risk Factors | 1997 |
3 trial(s) available for fosinopril and Arteriosclerosis
| Article | Year |
|---|---|
Plaque Hypertension Lipid-Lowering Italian Study (PHYLLIS): a protocol for non-invasive evaluation of carotid atherosclerosis in hypercholesterolaemic hypertensive subjects.
Topics: Aged; Arteriosclerosis; Carotid Artery Diseases; Clinical Protocols; Double-Blind Method; Female; Fosinopril; Humans; Hypercholesterolemia; Hypertension; Italy; Male; Middle Aged; Pravastatin; Ultrasonography | 1993 |
The hypertensive patient with multiple risk factors: is treatment really so difficult?
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Animals; Anticholesteremic Agents; Antihypertensive Agents; Arteriosclerosis; Clinical Trials as Topic; Coronary Disease; Female; Fosinopril; Humans; Hydrochlorothiazide; Hypercholesterolemia; Hypertension; Male; Middle Aged; Pravastatin; Risk Factors | 1997 |
Effect of fosinopril sodium on early carotid atherosclerosis in diabetic patients with hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteriosclerosis; Carotid Arteries; Carotid Artery Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diet Therapy; Female; Fosinopril; Humans; Hypertension; Male; Middle Aged; Tunica Intima; Tunica Media; Ultrasonography | 1997 |
7 other study(ies) available for fosinopril and Arteriosclerosis
| Article | Year |
|---|---|
Effects of fosinopril and valsartan on expressions of ICAM-1 and NO in human umbilical vein endothelial cells.
Topics: Arteriosclerosis; Cells, Cultured; Endothelium, Vascular; Fosinopril; Humans; Intercellular Adhesion Molecule-1; Lipoproteins, LDL; Nitric Oxide; Nitric Oxide Synthase; Tetrazoles; Umbilical Veins; Valine; Valsartan | 2003 |
Antiatherosclerotic effects of the angiotensin-converting enzyme inhibitors captopril and fosinopril in hypercholesterolemic minipigs.
Topics: Aldosterone; Animals; Arteriosclerosis; Blood Pressure; Captopril; Diet, Atherogenic; Female; Fosinopril; Hypercholesterolemia; Lipoproteins; Peptidyl-Dipeptidase A; Renin; Swine; Swine, Miniature | 1994 |
Regression of early atherosclerosis in hyperlipidemic hamsters induced by fosinopril and captopril.
Topics: Analysis of Variance; Animals; Aorta, Thoracic; Arteriosclerosis; Blood Pressure; Captopril; Cell Count; Cholesterol, Dietary; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Cricetinae; Diet, Atherogenic; Disease Models, Animal; Foam Cells; Fosinopril; Heart Rate; Hyperlipidemias; Image Processing, Computer-Assisted; Macrophages; Male | 1995 |
Inhibitors of angiotensin converting enzyme decrease early atherosclerosis in hyperlipidemic hamsters. Fosinopril reduces plasma cholesterol and captopril inhibits macrophage-foam cell accumulation independently of blood pressure and plasma lipids.
Topics: Animals; Aorta; Arteriosclerosis; Blood Pressure; Captopril; Cholesterol; Cricetinae; Foam Cells; Fosinopril; Heart Rate; Hyperlipidemias; Lipids; Macrophages; Male | 1994 |
Angiotensin converting enzyme inhibitors and atherosclerosis.
Topics: Acetylcholine; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteries; Arteriosclerosis; Captopril; Cholesterol; Diet, Atherogenic; Endothelium, Vascular; Female; Fosinopril; Hypercholesterolemia; Muscle Relaxation; Peptidyl-Dipeptidase A; Renin; Swine; Swine, Miniature | 1994 |
The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Apolipoproteins E; Arteriosclerosis; Drug Administration Schedule; Fosinopril; Hydralazine; Hypertension; Lipid Peroxidation; Lipoproteins, LDL; Losartan; Mice; Mice, Transgenic; Oxidation-Reduction; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2 | 1999 |
The effect of renin-angiotensin axis inhibition on early atherogenesis in LDL-receptor-deficient mice.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Body Weight; Cholesterol; Cholesterol, Dietary; Fosinopril; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, LDL; Renin-Angiotensin System; Sinus of Valsalva; Triglycerides | 2000 |